How can patient-specific induced pluripotent stem cells help scientists study genetic diseases?

Patient-specific induced pluripotent stem cells (iPS cells) are a powerful tool for studying genetic diseases because they allow scientists to create laboratory models that carry a patient's own specific genetic mutations.12

By reprogramming a patient’s adult somatic cells—such as skin cells—into a pluripotent state, researchers can generate cells that retain the donor's original genotype. These reprogrammed cells can then be stimulated to differentiate into the specific cell types affected by a disease, such as motor neurons for spinal muscular atrophy or cardiac cells for heart conditions.13

These models offer several critical advantages for medical research:

• Disease Recapitulation: Scientists can observe the cellular changes and functional insufficiencies as a disease progresses in a controlled laboratory environment.1
• Drug Screening: These cells provide a platform to test the safety and effectiveness of new drugs and therapeutic strategies tailored to specific genetic profiles.123
• Personalized Medicine: Because the cells are autologous (derived from the patient), they offer a path toward personalized treatments that minimize the risk of immune rejection.143

This approach has been used to study conditions such as amyotrophic lateral sclerosis and Alzheimer disease, providing deeper insights into disease mechanisms.3